Fri 6/5/2020 04:41 ET
DJIA26281.8213.140.05%TELCO173.391.140.66%GOLD1731.6018.351.06%Shanghai2911.587.570.26%
S&P 5003112.3510.580.34%BANKS375.8812.483.32%OIL35.341.634.61%BITCOIN9800.107.840.08%
NASDAQ9615.8166.350.69%PHARM609.724.390.72%US/EU1.130.000.07%Futures3057.2519.260.63%
Welcome Stranger!  Please sign up or log in to enable additional features.Sign Up | Mail | Log In
Forum - Neurocrine Biosciences - NBIX   

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add NBIX
  
From: Sqwii (Rep: 389)Date: 05/11/2012 03:47
Forum: Neurocrine Biosciences - Msg #1077Thread #673400691 (Rec: 0)
NBIX another one I like here at 6.96$ for some news coming near term this month



Urocortin 2 Update
The Christchurch Cardioendocrine Research Group at University of Otago, Christchurch School of Medicine and Health Sciences, New Zealand, in collaboration with the Company, is conducting a Phase II study of urocortin 2 in acute decompensated heart failure patients. This study is now complete and top-line results are expected shortly.

The Company has completed several Phase I studies and two Phase II studies of urocortin 2 in patients with stable congestive heart failure. These Phase II studies showed urocortin 2 to be well tolerated with positive hemodynamic effects as evidenced by increases in cardiac output and efficiency.



Started my own blog www.SqwiiTrader.com

What would you like to do? Message: Endorse | Bookmark | Report AbuseUser Sqwii: Reward | Watch | IgnoreNBIX: Ignore

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add NBIX
  

TheLion.com | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999- TheLion.com, Inc.